ClinicalTrials.Veeva

Menu

Gabapentin in Phantom and Stump Pain

D

Danish Pain Research Center

Status and phase

Completed
Phase 4

Conditions

Amputation of Lower Limb

Treatments

Drug: Gabapentin

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00169013
Gabapentin2002

Details and patient eligibility

About

To investigate whether gabapentin can prevent phantom and stump pain after amputation.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Amputation of crus or femur

Exclusion criteria

  1. Patients who cannot cooperate
  2. Fertile women without sufficient contraceptives
  3. Allergy to gabapentin
  4. Earlier amputation of the same limb except toes
  5. Serious lever, kidney, cardiac, respiratory, haematological disease.-

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems